Invesco Ltd. Atara Biotherapeutics, Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.44 - $1.22 $15 - $43
-36 Reduced 0.1%
34,507 $23,000
Q4 2023

Feb 12, 2024
BUY
$0.23 - $1.74 $1,275 - $9,648
5,545 Added 19.12%
34,543 $17,000
Q3 2023

Nov 13, 2023
BUY
$1.41 - $2.31 $197 - $323
140 Added 0.49%
28,998 $42,000
Q2 2023

Aug 11, 2023
SELL
$1.5 - $3.04 $5,347 - $10,837
-3,565 Reduced 11.0%
28,858 $46,000
Q1 2023

May 12, 2023
SELL
$2.8 - $5.46 $108,004 - $210,608
-38,573 Reduced 54.33%
32,423 $94,000
Q4 2022

Feb 13, 2023
SELL
$2.85 - $5.18 $1,684 - $3,061
-591 Reduced 0.83%
70,996 $232,000
Q3 2022

Nov 14, 2022
SELL
$2.85 - $8.73 $5,175 - $15,853
-1,816 Reduced 2.47%
71,587 $271,000
Q2 2022

Aug 15, 2022
BUY
$4.69 - $9.84 $39,719 - $83,334
8,469 Added 13.04%
73,403 $572,000
Q1 2022

May 16, 2022
BUY
$8.44 - $16.89 $150,957 - $302,094
17,886 Added 38.02%
64,934 $603,000
Q4 2021

Feb 14, 2022
SELL
$14.7 - $19.89 $73,794 - $99,847
-5,020 Reduced 9.64%
47,048 $742,000
Q3 2021

Nov 15, 2021
BUY
$11.99 - $17.9 $49,770 - $74,302
4,151 Added 8.66%
52,068 $933,000
Q2 2021

Aug 17, 2021
BUY
$12.89 - $16.58 $151,560 - $194,947
11,758 Added 32.52%
47,917 $745,000
Q1 2021

May 17, 2021
SELL
$14.0 - $20.72 $28,574 - $42,289
-2,041 Reduced 5.34%
36,159 $519,000
Q4 2020

Feb 16, 2021
BUY
$12.67 - $26.23 $135,556 - $280,634
10,699 Added 38.9%
38,200 $750,000
Q3 2020

Nov 16, 2020
SELL
$11.92 - $15.87 $7,402 - $9,855
-621 Reduced 2.21%
27,501 $357,000
Q2 2020

Aug 14, 2020
SELL
$7.53 - $14.93 $21,776 - $43,177
-2,892 Reduced 9.32%
28,122 $409,000
Q1 2020

May 15, 2020
BUY
$5.69 - $17.78 $176,469 - $551,428
31,014 New
31,014 $264,000

Others Institutions Holding ATRA

# of Institutions
7
Shares Held
2.89M
Call Options Held
0
Put Options Held
0
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $776M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email